Throughout 2024, MedTech stocks held a significant position in the portfolio of several investors. Despite several macroeconomic softnesses, the dynamic nature of the sector, marked by innovation and resilience, attracted investors throughout the year. The industry experienced significant growth and innovation, driven by technological advancements and increasing demand for personalized healthcare solutions. As the healthcare landscape continues to evolve, the MedTech sector, encompassing medical devices, di ...

Shares of Penumbra Inc PEN recovered slightly in early trading on Tuesday, after a week of correction.The Alameda, California-based company is likely to gain market share in the mechanical thrombectomy (MT) segment, according to Oppenheimer.MT is a minimally invasive procedure that removes a blood clot from an artery.Analyst Steven Lichtman initiated coverage of Penumbra with an Outperform rating and a price target of $275.The Penumbra Thesis: The company could generate mid-teens sales growth and over 30% e ...

Penumbra, Inc.’s (PEN) robust portfolio expansion efforts are poised to help it grow in the upcoming quarters. The company expects impressive growth as it expands globally throughout the rest of 2024 and beyond. A robust solvency position also bodes well for the stock. Meanwhile, macroeconomic volatilities and fiercely competitive space remain a concern for Penumbra.  In the past year, shares of this Zacks Rank #2 (Buy) company have rallied 7.1% compared with the industry’s 14.5% growth and the S&P 500 comp ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks ...

ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024.Event:     Piper Sandler 36th Annual Healthcare ConferenceDate:      Wednesday, December 4, 2024Time:      8:00am ET/5:00am PTA webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Gro ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style ...

Penumbra, Inc. (PEN) reported third-quarter 2024 adjusted earnings per share (EPS) of 85 cents, which surpassed the Zacks Consensus Estimate by 23.2%. Adjusted EPS improved 26.9% year over year.GAAP earnings were 75 cents per share, a 226% jump from the year-ago GAAP earnings of 23 cents per share.Following the earnings announcement, shares of PEN rose 1.3% in after-market trading yesterday.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Q3 Revenues of PENPenumbra registered revenue ...

Penumbra, Inc. (NYSE:PEN) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - Chairman and Chief Executive Officer Maggie Yuen - Chief Financial Officer Jason Mills - Executive Vice President of Strategy Conference Call Participants Richard Newitter - Truist Securities Robert Marcus - JPMorgan Joanne Wuensch - Citi Michael Sarcone - Jefferies Samantha Kurtz - Piper Sandler Michael Kratky - ...

Penumbra (PEN) reported $301.04 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 11.1%. EPS of $0.85 for the same period compares to $0.67 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $298.09 million, representing a surprise of +0.99%. The company delivered an EPS surprise of +23.19%, with the consensus EPS estimate being $0.69. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...